Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 1
Recruiting
Sponsor: AbbVie
No Placebo Group
Trial Summary
What is the purpose of this trial?This study will assess the relative bioavailability and effect of food on pharmacokinetics of ABBV-932 oral administration in healthy adult participants.
Eligibility Criteria
This trial is for healthy adults who can safely take the experimental medication ABBV-932. Specific eligibility criteria are not provided, but typically participants must meet certain health standards and not be taking conflicting medications.Exclusion Criteria
I don't have any serious health issues apart from my current condition.
I have a history of epilepsy.
Participant Groups
The study is testing ABBV-932, an oral medication. It aims to understand how the body absorbs it (bioavailability) and how food affects its absorption (pharmacokinetics).
5Treatment groups
Experimental Treatment
Group I: ABBV-932: Arm EExperimental Treatment1 Intervention
Participants will receive a single dose of ABBV-932 Arm E on day 1 with a high-fat meal.
Group II: ABBV-932: Arm DExperimental Treatment1 Intervention
Participants will receive a single dose of ABBV-932 Arm D on day 1 with a high-fat meal.
Group III: ABBV-932: Arm CExperimental Treatment1 Intervention
Participants will receive a single dose of ABBV-932 Arm C on day 1 under fasting conditions.
Group IV: ABBV-932: Arm BExperimental Treatment1 Intervention
Participants will receive a single dose of ABBV-932 Arm B on day 1 under fasting conditions.
Group V: ABBV-932: Arm AExperimental Treatment1 Intervention
Participants will receive a single dose of ABBV-932 Arm A on day 1 under fasting conditions.
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Acpru /Id# 266649Grayslake, IL
Loading ...
Who is running the clinical trial?
AbbVieLead Sponsor